James S Blachly Selected Research

James S Blachly Research Topics

Disease

21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 12/2014
19	Neoplasms (Cancer) 02/2023 - 10/2013
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021 - 10/2013
5	Leukemia 01/2022 - 12/2019
5	Hairy Cell Leukemia 01/2021 - 01/2015
4	Lymphoma (Lymphomas) 10/2021 - 10/2014
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2016
2	Disease Progression 10/2021 - 12/2018
2	Infections 01/2019 - 01/2015
2	Melanoma (Melanoma, Malignant) 01/2017 - 01/2015
1	Atrial Fibrillation 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Hyponatremia 09/2023
1	Prostatic Neoplasms (Prostate Cancer) 11/2022
1	Hypoxia (Hypoxemia) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021
1	COVID-19 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020
1	Hyperbilirubinemia 11/2020
1	Exanthema (Rash) 11/2020
1	Venous Thromboembolism 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Pancytopenia 01/2019
1	Tetraploidy 08/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2016
1	Chronic Disease (Chronic Diseases) 04/2016
1	Lymphoid Leukemia 04/2016
1	Oncogene Addiction 02/2016

Drug/Important Bio-Agent (IBA)

7	ibrutinibIBA 01/2024 - 05/2017
3	Proteins (Proteins, Gene)FDA Link 09/2023 - 12/2016
3	gilteritinibIBA 09/2022 - 06/2020
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 12/2016
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 01/2016
2	selinexorIBA 09/2023 - 01/2020
2	Androgen Receptors (Androgen Receptor)IBA 11/2022 - 01/2020
2	fms-Like Tyrosine Kinase 3IBA 09/2022 - 11/2019
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 10/2021 - 02/2016
2	KPT-9274IBA 01/2021 - 12/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2016
2	Syk KinaseIBA 11/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2017
2	Long Noncoding RNAIBA 04/2017 - 12/2014
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2016 - 10/2013
1	trioctyl phosphine oxide (TOPO)IBA 09/2023
1	venetoclaxIBA 02/2023
1	AndrogensIBA 11/2022
1	Dihydroorotate DehydrogenaseIBA 09/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	crenolanibIBA 01/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	AntigensIBA 10/2021
1	Immunoglobulin Variable RegionIBA 10/2021
1	LectinsIBA 10/2021
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 10/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	IntegrinsIBA 10/2021
1	Intercellular Adhesion Molecule-3IBA 10/2021
1	Polysaccharides (Glycans)IBA 10/2021
1	purineIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2021
1	dubermatinibIBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 12/2020
1	Lenalidomide (CC 5013)FDA Link 12/2020
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 11/2020
1	pegaspargase (Oncaspar)FDA Link 09/2020
1	midostaurinIBA 06/2020
1	Decitabine FDA Link 01/2020
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	acalabrutinibIBA 01/2020
1	obinutuzumabIBA 01/2020
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	VemurafenibIBA 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Bendamustine Hydrochloride FDA Link 12/2018
1	Rituximab (Mabthera)FDA Link 12/2018
1	Neurofibromin 1 (Neurofibromin)IBA 12/2018
1	PLX51107IBA 01/2018
1	trametinibIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	CohesinsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 12/2016
1	InterferonsIBA 12/2016
1	daratumumabIBA 12/2016

Therapy/Procedure

17	Therapeutics 02/2023 - 10/2013
7	Drug Therapy (Chemotherapy) 09/2023 - 10/2013
1	Precision Medicine 01/2021
1	Cell Transplantation 12/2020
1	Induction Chemotherapy 11/2020
1	Aftercare (After-Treatment) 01/2019